Contraceptive Drugs and Devices Market Size, Key Companies, Trends, Segments, and Forecast 2026-2035

Revenue, 2026

USD 35.23 Bn

Forecast Year, 2035

USD 58.87 Bn

CAGR, 2026 - 2035

5.88%

Report Coverage

Global

What is the Contraceptive Drugs and Devices Market Size?

The global contraceptive drugs and devices market size was estimated at USD 35.23 billion in 2026 and is projected to reach approximately USD 58.87 billion by 2035, representing a CAGR of 5.88% from 2026 to 2035. The increase in the number of sexually transmitted diseases and unintended pregnancies is expected to drive market growth. Government efforts to spread awareness regarding contraception are also driving market growth. In addition, increasing government policies on controlling the population are further anticipated to enhance the contraceptive drugs and devices market growth

Contraceptive Drugs and Devices Market Key Takeaways

• In terms of revenue, the global contraceptive drugs and devices market was valued at USD 35.23 billion in 2026.
• It is projected to reach USD 58.87 billion by 2035.
• The market is expected to grow at a CAGR of 5.88% from 2026 to 2035.
• Asia Pacific dominated the contraceptive drugs and devices market with the largest market share of 35% in 2026.
• North America is expected to grow rapidly in the market during the forecast period.
• The U.S. dominated the North American market with a market share of 85% in 2026.
• By product, the contraceptive devices segment contributed the biggest market share of 69% in 2026.
• By product, the contraceptive drugs segment is expected to grow at a CAGR of 3.51% during the forecast period.
• By distribution channel, the retail pharmacy segment dominated the global market in 2026.
• By distribution channel, the online channels segment is expected to grow rapidly in the market during the forecast period.

Market Overview

Contraceptive drugs and devices market deals with surgical treatments, medicines, and medical devices that are used to prevent pregnancy. Contraceptive drugs and devices are used to prevent pregnancy. Condoms also reduce the risk of many sexually transmitted infections (STIs), while most other contraceptive methods do not provide STI protection. It might be permanent or temporary, and both women and men could benefit from it. Sterilization for women and men is a permanent process, whereas non-hormonal and hormonal procedures are only temporary. Other factors influencing demand include increased participation of women in the workforce, technological advances, and changes in population and family-planning needs.

How is AI Changing the Contraceptive Drugs and Devices Market?

Artificial intelligence (AI) is changing the contraceptive drugs and devices market by providing innovative solutions beyond traditional methods of birth control. AI may support reproductive-health research, fertility tracking, and personalized health information. Claims about AI-enabled contraceptive devices should be included only when supported by evidence of a commercially available or clinically validated product. It stands as an enhancing fore in generating a more inclusive, effective, and personalized approach to contraception beyond traditional birth control pills. Advanced algorithms provide personalized fertility window predictions by analyzing factors such as hormonal fluctuations, cervical mucus patterns, and basal body temperature. These applications may support research into non-hormonal contraceptive methods, although their effectiveness and clinical utility require validation. Furthermore, AI-generated tracking techniques go beyond traditional methods. AI can assist in identifying non-hormonal methods tailored to individual preferences and health considerations by analyzing data related to fertility indicators and reproductive health.

Contraceptive Drugs and Devices Market Growth Factors

• The increasing focus of regional and national healthcare agencies and non-profit organizations on promoting women's sexual wellness and reproductive health contributed to propel the market growth.
• The increasing availability of favorable reimbursement policies in the developed and the increasing number of products being launched in the market by major domestic and global players are expected to drive the market growth.
• Government and nonprofit initiatives that improve affordability, access, and awareness of contraceptive methods may support adoption.

Market Dynamics

Driver

The growing emphasis of major healthcare organizations and manufacturers

The increasing prevalence of major healthcare organizations and manufacturers raising awareness of contraception options is the major driver of market growth. Various issues, including supply chain disruption, were blamed for his higher revenue drop. In addition, there have been significant disruptions of family planning and contraception services in various countries. Government family-planning programs, demand for pregnancy prevention, and increased access to reproductive-health services may support demand for contraceptive drugs and devices. Since they are growing more commonplace globally, unwanted pregnancies are a major concern. Due to this, the increase in unwanted pregnancies is expected to increase demand for contraceptive devices and medications.

Restraint

Side effects associated with drugs and lack of awareness

Potential adverse effects vary by contraceptive method and may include irregular bleeding, headaches, nausea, or other method-specific effects. Various research studies have been published to highlight the long-term side effects associated with birth control drugs. In addition, social taboos and lack of awareness about contraception methods are accountable for the low adoption of drugs and devices in emerging countries. Furthermore, the availability of alternative contraceptive methods such as IUDs, condoms, and other physical barriers are effective side effects.

Opportunity

Rapidly growing product portfolio

The increasing number of new product launches and a rise in disposable income in developed and advancing countries are expected to offer significant opportunities for market growth in the coming year.

Segment Insights

Product Insights

The contraceptive devices segment dominated the contraceptive drugs and devices market in 2026. The contraceptive devices segment is further classified into diaphragms, subdermal implants, vaginal rings, condoms, and intrauterine devices. The segment growth is driven by increasing awareness regarding contraceptive devices as public and government welfare groups have been active in spreading awareness related to unwanted pregnancies. Contraceptive devices are effective in preventing unwanted pregnancies and the spreading of STDs. In addition, major market players are investing significantly in emerging advanced contraceptive devices such as subdermal implants, vaginal rings, condoms and intrauterine devices, and more.

The contraceptive drugs segment is expected to grow at the fastest rate in the contraceptive drugs and devices market during the forecast period, leading to increasing awareness regarding preventive measures such as injectables, patches, and pills, and unwanted pregnancies. The growing acceptance and increased accessibility of contraceptive drugs across the urban population are fueling the market growth of this segment, as the population is giving higher importance to family planning and sexual health.

Distribution Channels Outlook Insights

The retail pharmacy segment dominated the global contraceptive drugs and devices market in 2026. The availability and prescription requirements for oral contraceptives vary by country and product. Add country-specific claims only with current regulatory or government-health sources. This factor has led to a significant shift of customers toward retail pharmacies for acquiring birth control pills. Also, the increasing awareness about various contraception methods and increasing demand for OTC contraception drugs across the general population.

The online channels segment is expected to grow rapidly in the contraceptive drugs and devices market during the forecast period. The segment growth is responsible for the increasing adoption of over-the-counter services coupled with various online discounts and offers to attract customers. In addition, the all-time availability of these drugs and a wide distribution channel such as patches, injectables, and oral pills of different brands.

Regional Insights

What is the Asia Pacific Contraceptive Drugs and Devices Market Size?

The Asia Pacific contraceptive drugs and devices market size was exhibited at USD 12.33 billion in 2026 and is anticipated to reach around USD 20.98 billion by 2035, growing at a CAGR of 6.07% from 2026 to 2035.

Asia Pacific dominated the contraceptive drugs and devices market in 2026. The market growth in the region is fueled by the increasing prevalence of unwanted pregnancies and STDs and the rising population. To mitigate problems such as STDs, abortion, and unwanted pregnancies, urban populations in the region have increased the use of contraceptive measures.

China is an important healthcare market in Asia Pacific. Its share and growth rate in the contraceptive drugs and devices market should be stated only when supported by the underlying country-level forecast data. The market growth is driven by growing awareness about unwanted pregnancies and STDs and the presence of major manufacturing companies. Due to the presence of a developed cheap labor and manufacturing sector, Major pharmaceutical companies can manufacture contraceptive products in huge numbers. In addition, due to the country's strong distribution channel, the products are deployed quickly to the customers. Additionally, the increased population has been due to the government putting more initiatives to educate the population about contraceptive measures.

North America's Contraceptive Market Growth Driven by Public Health Awareness and Government Support

North America is expected to grow rapidly in the contraceptive drugs and devices market during the forecast period. The market growth in the region is attributed to the increasing initiatives taken by the government to make people aware of unwanted pregnancies and STDs. The government has also been active in offering contraceptive measures in the funded medical institutes of the government. In addition, the increasing focus on family planning by the rising population due to the rise in STDs and unwanted population has resulted in the increased sale of contraceptive devices and drugs in the Asia Pacific.

The U.S. will dominate the North American contraceptive drugs and devices market in 2026. The major factors expected to the market growth in the U.S. are widespread access to an increase in the awareness of unwanted pregnancies and STDs and contraceptive measures. So many options for contraceptive measures are present in healthcare, making contraceptive devices and drugs more accessible to the population. In addition, increasing awareness by public and government welfare groups about abortions and STDs.

What Are the Driving Factors of The Contraceptive Drugs and Devices Market in Europe?

Europe is expected to grow at a significant CAGR during the forecast period, driven by high use of modern methods and favorable government policies such as free contraceptives in France. The growth is stimulated by an increase in the demand for hormonal implants and IUDs, telemedicine development, and dispensing by pharmacists, and a growing interest in non-hormonal and sustainable contraceptives.

Germany Market Trends

Interest in non-hormonal contraception and fertility-awareness products is a potential trend in Germany; add evidence from a current German or European health source before presenting it as established demand growth. Long-acting reversible contraceptives and access to emergency contraception are becoming more and more innovative. Pharmacies are important in consultation and dispensing, which serve to make contraceptives more available and help grow contraceptive use among the demographics.

What Are the Driving Factors of The Contraceptive Drugs and Devices Market in Latin America?

Latin America is expected to grow at a remarkable CAGR during the forecast period. There is a robust growth in Latin America, backed by government programs of free contraception, especially in Brazil. The high numbers of unplanned pregnancies push the demand for long-acting contraceptive methods. Better sexual health awareness and education, coupled with enhanced emphasis on family planning among the younger populations, also enhance the adoption rates in the region.

Brazil Market Trends

The Brazilian market is also consumer-led by the government programs and campaigns that encourage free access to IUDs and implants within the public healthcare systems. Distribution is dominated by retail pharmacies, and e-commerce is growing at a rapid pace. The innovative barrier techniques, such as non-latex and hypoallergenic condoms, are on the rise as more people are becoming aware of the various needs of consumers.

How is the Middle East & Africa Performing in The Contraceptive Drugs and Devices Market?

The Middle East & Africa are expected to grow at a notable CAGR during the forecast period. The MEA region undergoes high growth because of growing investments in reproductive healthcare and new reimbursement plans. There is more access to contraception, especially in South Africa, through government awareness efforts and NGO efforts. There are emerging innovative solutions, such as vending machines, to provide discreet access to high levels of unintended pregnancies.

South Africa Market Trends

South Africa is promoting the supply of contraceptives with innovative distribution channels, such as vending machines, which offer free commodities. Good emphasis on policies related to reproductive health that meet international standards assists in accessibility. Specific attention is paid to rural and underserved groups to decrease unintended pregnancies and enhance overall reproductive healthcare outcomes.

Contraceptive Drugs and Devices Market Companies

• Abbvie, Inc.
• Afaxys, Inc.
• Agile Therapeutics
• Bayer AG
• China Resources (Holdings) Co., Ltd.
• Church & Dwight Co., Inc.
• Cupid Limited
• Helm AG
• Johnson & Johnson Services, Inc.
• Organon Group of Companies
• Pfizer Inc.
• Veru, Inc.
• Viatris Inc.

Recent Developments

• In January 2026, Organon announced FDA approval for NEXPLANON's supplemental New Drug Application, extending its contraceptive use duration from three to five years, with no reported pregnancies or safety issues during clinical trials. (Source: https://www.organon.com )
• In June 2025, Inne, a Berlin-based startup, announced that it received regulatory approval for its saliva-based fertility tracker, Minilab, for use as a contraceptive in Europe. The device is a non-invasive alternative to hormonal birth control methods that tracks daily changes in progesterone levels. (Source: https://thenextweb.com )

Contraceptive Drugs and Devices Market Segment

By Product

• Contraceptive Drugs
  • Contraceptive Pills
  • Patch
  • Injectable
• Contraceptive Devices
  • Condoms
    • Male Condoms
    • Female Condoms
  • Subdermal Implants
  • Intrauterine Devices (IUDs)
    • Copper IUDs
    • Hormonal IUDs
  • Vaginal Ring
  • Diaphragm

By Distribution Channels Outlook

• Hospital Pharmacy
• Retail Pharmacy
• Clinics
• Online Channels
• Public Channels & NGOs
• Other

By Geography

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa